How Rare Disease Treatments Are Driving the Human Blood Plasma Fractionation Industry
The increasing prevalence of immune deficiencies, bleeding disorders, and rare chronic diseases is driving the demand for human blood plasma fractionation products worldwide. However, the market also faces several challenges. Limited plasma donation rates, high costs associated with plasma collection and fractionation, stringent regulatory requirements, and complex manufacturing...
0 Commentaires 0 Parts 213 Vue 0 Aperçu